Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Solana CompanyNASDAQ: HSDT
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 296.3% from a year ago
Cash & equivalents stood at $4.4M at the end of Q1 FY2026, up 296.3% from a year earlier and down 39.6% from the prior quarter. Over 3 fiscal years it compounded at -20.6% a year.
Context
- Cash & equivalents amounted to 2.2% of total assets at the end of Q1 FY2026, down 29.6 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +296.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 7.28M USD
- Year-over-year change
- +569.3%
- 4-year CAGR
- -9.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.28M | +569.3% |
| FY2024 | 2024-12-31 | 1.09M | -79.0% |
| FY2023 | 2023-12-31 | 5.18M | -64.4% |
| FY2022 | 2022-12-31 | 14.55M | +32.2% |
| FY2021 | 2021-12-31 | 11.01M | — |
Cash & Equivalents vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's Mar 2026 cash & equivalents of $4.4M is the 10th highest of the 11 companies compared; the peer median is $42.67M.
- Its year-over-year change of +296.3% is the 2nd highest of 11, against a peer median of +16.5%.
- Cash & equivalents amounts to 2.2% of total assets for HSDT, versus a peer median of 28.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $94.41M | -20.6% | -17.8% | 33.0% | |
| Mar 2026 | $56.55M | +335.0% | +29.5% | 79.7% | |
| Mar 2026 | $53.97M | +21.5% | +13.4% | 13.1% | |
| Mar 2026 | $50.46M | +8.7% | +20.7% | 68.5% | |
| Dec 2025 | $49.15M | +25.1% | +8.5% | 30.3% | |
| Mar 2026 | $36.18M | -52.7% | -55.5% | 9.9% | |
| Mar 2026 | $30.56M | -59.7% | -21.8% | 12.3% | |
| Mar 2026 | $16.99M | +11.5% | +23.3% | 28.6% | |
| Mar 2026 | $10.78M | +26.8% | +118.1% | 29.1% | |
| Mar 2026 | $4.4M | +296.3% | -20.6% | 2.2% | |
| Mar 2026 | $2.11M | +39.8% | +168.3% | 2.1% | |
| Peer median (excluding HSDT) | $42.67M | +16.5% | +17.1% | 28.8% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 11.01M | 14.55M | 5.18M | 1.09M | 7.28M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 251K | 343K | 637K | 635K | 0 |
| Inventory | 476K | 589K | 457K | 1.09M | 1.12M |
| Other Current Assets | 0 | 399K | 333K | 7K | 21.07M |
| Total Current Assets | 12.59M | 16.7M | 7.3M | 3.42M | 31.16M |
| Property, Plant & Equipment (Net) | 412K | 450K | 230K | 118K | 0 |
| Goodwill | 763K | 0 | 0 | 0 | 0 |
| Intangible Assets | 333K | 140K | 24K | 0 | 196.72M |
| Long-term Investments | 0 | 0 | 0 | 0 | 75.98M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 140K | 0 | 75K |
| Total Non-current Assets | 1.51M | 590K | 394K | 118K | 272.77M |
| Total Assets | 14.1M | 17.29M | 7.69M | 3.54M | 303.93M |
| Account Payables | 1.07M | 627K | 531K | 873K | 1.89M |
| Short-term Debt | 3K | 54K | 45K | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 148K | 27K | 43K | 39K | 0 |
| Other Current Liabilities | 721K | 771K | 751K | 859K | 316K |
| Total Current Liabilities | 2.65M | 1.99M | 1.88M | 2.16M | 3.02M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 193K | 175K | 128K | 79K | 0 |
| Other Non-current Liabilities | 0 | 6.92M | 3.32M | 241K | 0 |
| Total Non-current Liabilities | 193K | 7.15M | 3.46M | 320K | 0 |
| Total Liabilities | 2.85M | 9.14M | 5.34M | 2.48M | 3.02M |
| Common Stock | 4K | 28K | 1K | 4K | 44K |
| Retained Earnings | (137.04M) | (151.11M) | (159.96M) | (171.7M) | (212.59M) |
| Accumulated OCI | (1.13M) | (388K) | (673K) | 333K | (261K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 11.26M | 8.15M | 2.35M | 1.06M | 300.91M |
| Total Debt | 3K | 110K | 57K | 12K | 0 |
| Net Debt | (11M) | (14.44M) | (5.13M) | (1.08M) | (7.28M) |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.